Not much has changed in a week,,,...... Insmed is not a buyout candidate until a strong revenue stream is seen...the company is a ways from a filing and approval. zake1, I think it was the last CC that Lewis confirmed what Wedbush has been saying for awhile...that NTM results will be in the first quarter,which is actually a better time (January effect) for bio news ,,,Good Luck
I agree with most of your post. I would say that if we do get some positive news, as suitor
maybe best served to make a takeover try prior to an actual revenue stream being accomplished.
This Lewis guy isn't one to hesitate to surprise the market with additional indications, and the
announcement of trials for such. He seems to have a flair, witnessed by the fact that he staged
a pretty impressive conference call with doctors, and industry consultants during his last
review. These kind of tactics could push the price up in advance of an offer.